BCM
TVGN icon

Bridgeway Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bridgeway Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,650
Closed -$27.3K – 1322
2025
Q4 		$27.3K Hold
1,650
– – ﹤0.01% 1203
2025
Q3 		$64.8K Buy
1,650
+660
+67% +$32.5K ﹤0.01% 1148
2025
Q2 		$61.9K Buy
+990
New +$56.4K ﹤0.01% 1122

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bridgeway Capital Management's TVGN Position: Q1 2026 in Review

Bridgeway Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2026, closing a stake of 1,650 shares — an estimated $27.3K sold.

Bridgeway Capital Management first reported a position in TVGN in Q2 2025 and held it in 3 quarters. The position peaked at $64.8K in Q3 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Bridgeway Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 1,650 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $27.3K.
  • Bridgeway Capital Management first reported a position in Tevogen Inc. Common Stock in Q2 2025 and held it in 3 quarters.
  • Bridgeway Capital Management's Tevogen Inc. Common Stock position peaked at $64.8K in Q3 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.